Kario, Kazuomi
Tomitani, Naoko
Wang, Tzung-Dau
Park, Sungha
Li, Yan
Shin, Jinho
Tsoi, Kelvin
Chen, Chen-Huan
Cheng, Hao-Min
Siddique, Saulat
Turana, Yuda
Buranakitjaroen, Peera
Van Huynh, Minh
Nailes, Jennifer
Sison, Jorge
Soenarta, Arieska Ann
Sogunuru, Guru Prasad
Sukonthasarn, Apichard
Tay, Jam Chin
Teo, Boon Wee
Verma, Narsingh
Zhang, Yuqing
Schlaich, Markus
Nagai, Michiaki
Fujiwara, Takeshi
Hoshide, Satoshi
Chia, Yook-Chin
Wang, Ji-Guang
Article History
Received: 21 April 2023
Revised: 20 June 2023
Accepted: 12 July 2023
First Online: 21 August 2023
Compliance with ethical standards
:
: KK reports funded/joint research fees and lecture fees from Omron Healthcare, A&D; and research fees from Fukuda Denshi. YL reports having received research grants from A&D, Bayer, Omron, Salubris and Shyndec, and lecture fees from A&D, Omron, Servier, Salubris and Shyndec. J-GW reports having received lecture and consulting fees from A&D, Novartis, Omron, Servier, and Viatris. CY-C has received unrestricted educational grants from Viatris and Omron and from Medtronic for activities of the Malaysian Society for World Action on Salt, Sugar and Health (MyWASSH) CYC also has received speaker honoraria from Medtronic, Astra-Zeneca, Omron, Viatris and Xepa-Sol. JS has received honoraria and sponsorship to attend seminars from Daiichi Sankyo, Menarini, Organon, Bristol-Myers Squibb, and Sanofi. C-HC reports Honoraria from Novartis and Daiichi Sankyo outside the submitted work. H-MC served as a speaker or member of speakers bureau AstraZeneca; Pfizer Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Novartis Pharmaceuticals, Inc.; SERVIER; Co., Pharmaceuticals Corporation; Sanofi; TAKEDA Pharmaceuticals International; Eli Lilly; Received grants for clinical research from Microlife Co., Ltd. SS has received honoraria from Bayer, Getz Pharma, Novartis, Pfizer, ICI, and Servier; and travel, accommodation, and conference registration support from Hilton Pharma, Atco Pharmaceutical, Highnoon Laboratories, Horizon Pharma and ICI. MPS is supported by an NHMRC Research Fellowship and has received consulting fees, and/or travel and research support from Metavention, Medtronic, Abbott, Novartis, Servier, Pfizer, and Boehringer-Ingelheim.